One suggested factor was a change in prescribing practices, in that inhaled β2-AR agonists, along with sustained-release theophylline preparations, were prescribed in place of inhaled corticosteroids and cromolyn [149], possibly predisposing to fatal cardiac arrhythmias. Here, ADRB2 is linked to chronic obstructive pulmonary disease.